Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of a new startup, TenAces.
TenAces will utilize AI, integrating biology and machine learning algorithms, to discover molecular glue therapies to enhance targeted protein degradation.
Molecular glues are protein-binding small molecules that change two protein...
Amazon Pharmacy and hybrid primary care provider One Medical have launched a pilot program to expand Amazon's hybrid primary care offerings by giving One Medical providers the ability to request medication consultations for patients with complex medication regimens.
The focus of the pilot, which launched in the fourth quarter of 2023, has been on elderly patients who are managing multiple chronic...
Between 30% to 50% of cancer cases are preventable, according to the World Health Organization. Precluding the advancement of cancer can save patients and payers money and lead to a better quality of life.
Feyi Ayodele, founder and CEO at CancerIQ, sat down with MobiHealthNews to discuss CancerIQ's offerings and how healthcare organizations use its technology to detect and thwart the...
The healthcare sector witnessed a significant transformation in 2023, largely driven by the integration of artificial intelligence (AI) in patient diagnostics. This integration marks a revolutionary step in how medical professionals approach diagnosis, offering a blend of efficiency, accuracy and personalization previously unattainable.
The dawn of AI-driven diagnostics
Artificial intelligence in...
WellTheory, a virtual care platform for individuals with autoimmune diseases, announced its first employer partnership with Maven Clinic to offer the virtual women and family health provider's employees access to nutrition and lifestyle coaching from WellTheory.
WellTheory provides patients with two virtual visits per month and unlimited messaging with coaches specializing in autoimmune diseases...
Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million.
Venture Investors Health Fund and the State of Wisconsin Investment Board (SWIB) led the round.
Existing investors Northpond Ventures, Moore Strategic Ventures, WARF Ventures, Tao Invest, Sands Capital and ARCH Ventures also participated in the...
A government-funded initiative to seamlessly connect hospitals, government, insurers, and medical device manufacturers in the whole care process based on digital therapeutics and big data has commenced at Yonsei University Health System.
Yonsei's Severance Hospital recently started prescribing the insomnia DTx Somzz through the integrated platform called Connect-DTx.
HOW IT WORKS
Connect-DTx can...
Samsung to integrate Lunit's AI in premium X-ray devices
South Korean medical AI provider Lunit has signed a three-year supply contract with Samsung Electronics.
The deal is for the integration of Lunit's two chest X-ray AI solutions – Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage – into Samsung's line of premium X-ray devices.
According to a press release, the AI-integrated X-ray devices will...
Editor's note: This article has been updated with a statement from Google.
Behemoth lab test company Quest Diagnostics is partnering with Google's Fitbit to study how wearable technologies can improve metabolic health.
The pilot study, dubbed Wearables for Metabolic Health (WEAR-ME), will combine Fitbit's behavioral and biometric data with health information from Quest Diagnostics' lab tests to...
New player in digital diabetes management
Diabetes app Smit.fit from India and Qatar-based digital therapeutics (DTx) company Droobi Health have announced their merger.
The combined entity called DroobiSmit, headquartered in Singapore, aims to be a leading diabetes solution provider in the Middle East and South Asia regions. It will offer personalised solutions for people with pre-diabetes,...
.jpeg?itok=Rt3dZ84x "Google Fitbit Charge 6")
